Company profile: Kumovis
1.1 - Company Overview
Company description
- Provider of medical technology, developing a 3D printer with clean room integration.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Kumovis
BlinkBio
HQ: United States
Website
- Description: Provider of specialized bioorthogonal chemistries for the delivery of next-generation medicines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BlinkBio company profile →
Ahura Scientific
HQ: United States
Website
- Description: Provider of rugged, ultra-compact, field-enabled optical systems for the immediate identification and authentication of liquid and solid chemical substances, serving homeland security, life sciences, industrial, and medical markets; products include handheld XRF and LIBS analyzers, portable narcotics and chemical identifiers, manufactured in the USA in an ISO 9001-certified facility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ahura Scientific company profile →
Element Biosciences
HQ: United States
Website
- Description: Provider of innovative genetic analysis tools, including the AVITI System benchtop sequencer with dual flow cell capacity; AVITI24 integrating sequencing and Teton CytoProfiling to analyze DNA, RNA, proteins, and cell morphology from a single sample; Teton Assays targeting oncology, immunology, neuroscience; Cloudbreak Freestyle Kits to streamline AVITI workflows; and Avidity Sequencing for highly accurate, efficient data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Element Biosciences company profile →
Remedy Plan
HQ: United States
Website
- Description: Provider of pre-clinical cancer therapeutics developing first-in-class small molecule drugs that differentiate cancer cells, including RPT1G, a clinical candidate targeting NAMPT for solid and hematological malignancies. Offers NAMPT programs in oncology, autoimmune, and obesity, and a proprietary high-throughput phenotypic drug screening platform targeting critical pathways in cancer stem cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Remedy Plan company profile →
Recombia
HQ: United States
Website
- Description: Provider of synthetic biology and genome engineering solutions, offering yeast strain optimization, metabolic engineering, and microbial strain engineering to enhance industrial fermentation, produce natural products, and support various industrial applications using rationally designed genetic modifications with high precision, efficiency, and throughput.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Recombia company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Kumovis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Kumovis
2.2 - Growth funds investing in similar companies to Kumovis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Kumovis
4.2 - Public trading comparable groups for Kumovis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →